In November 2022, Merck KGaA (Switzerland) invested USD 306.5 million in expanding its biosafety testing capacity at Rockville, Maryland, US. This site will provide biosafety testing and analytical development services in the US.
Northbrook, IL 60062 -- (SBWIRE) -- 09/20/2023 -- The global sterility testing market is poised for significant growth, with projections indicating an impressive surge from USD 1.1 billion in 2023 to USD 1.9 billion in 2028, at a compelling Compound Annual Growth Rate (CAGR) of 10.5%. In this article, we will delve into the factors driving this remarkable growth and explore the challenges that the market faces.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=208866931
Browse in-depth TOC on "Sterility Testing Market"
178 – Tables
35 – Figures
198 – Pages
Factors Fueling Market Growth:
1. Pharmaceutical & Biopharmaceutical Expansion: A pivotal driver of this growth is the continuous expansion of pharmaceutical and biopharmaceutical production capacities. This expansion is fueled by the ever-growing demand for high-quality pharmaceutical products on a global scale.
2. Novel Biopharmaceutical Development: The market is further propelled by the increasing development of innovative biopharmaceutical products. This surge in novel product development has created a need for robust sterility testing to ensure the safety and efficacy of these cutting-edge therapies.
3. Investments in Life Science Research: The healthcare and life sciences sectors have witnessed a surge in investments. These investments are directed towards groundbreaking research and development initiatives, thus creating a heightened demand for sterility testing solutions.
Challenges Hindering Market Growth:
1. Rise of Single-Use Technology: One significant challenge faced by the sterility testing market is the growing adoption of single-use technology. While this trend is environmentally friendly and cost-effective, it poses a threat to traditional sterility testing methods.
Key Market Player
Prominent players operating in the biomarkers market are Charles River Laboratories, Inc. (US), Merck KGaA (Germany), bioMérieux SA (France), SGS SA (Switzerland), WuXi AppTec (China), Nelson Laboratories, LLC (US), Pacific BioLabs (US), Sartorius AG (Germany), Thermo Fisher Scientific Inc. (US), Samsung Biologics (South Korea). The study includes an in-depth competitive analysis of these key players in the modular data center market with their company profiles, recent developments, and key market strategies. The players in this market have embraced different strategies to expand their global presence and increase their market shares. New product launches and enhancements, partnerships, acquisitions, and collaborations have been the most dominating strategies adopted by the major players.
Request Free Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=208866931
The kits & reagents segment accounted for the largest share of the product & service segment in 2022
On the basis of product & service, the sterility testing market is segmented into kits & reagents, instruments, and services. In 2022, the kits & reagents segment accounted for the largest market share in sterility testing. Kits & reagents are widely used in the pharmaceutical and biotechnology industries as it is easy to use. Moreover, the long shelf life of these products is contributing to their rising adoption in academic institutions and contract research organizations.
By test-type segment, membrane filtration accounted for the largest market share in 2022
Based on the test type, the sterility testing market is divided into membrane filtration, direct inoculation, and other tests. The membrane filtration segment accounted for the biggest share of the sterility testing market in 2022. Factors such as the growing demand for sterility testing of liquid dose formulations and the utility of such tests in samples containing preservatives and bacteriostatic & fungistatic compounds will boost segmental growth.
In 2022, the Asia region accounted as the fastest-growing region in the market
In 2022, the Asia region accounted for the fastest-growing region of the sterility testing market. Factors responsible for the growth of this region include the rising trend of outsourcing pharmaceutical activities to CROs and CDMOs coupled with growing demand from emerging markets such as China and India.Moreover, growing public and private investments in pharmaceutical and biopharmaceutical R&D activities in the region will also propel the growth of Asian sterility testing market over the forecast period.
Request 10% Customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=208866931
- In November 2022, Merck KGaA (Switzerland) invested USD 306.5 million in expanding its biosafety testing capacity at Rockville, Maryland, US. This site will provide biosafety testing and analytical development services in the US.
- In September 2022, Merck KGaA (Switzerland) opened its viral clearance (VC) laboratory as the first phase of the China Biologics Testing Center. This site is set to operate in China and will locally conduct viral clearance studies across pre-clinical development to commercialization.
- In June 2022, Charles River Laboratories, Inc. (US) opened a new facility of High Quality (HQ) Plasmid DNA Centre of Excellence at Bruntwood SciTech's Alderley Park in Cheshire, UK. The 16,000 sq. ft facility will provide plasmid DNA manufacturing services.
- In May 2022, bioMerieux SA (France) acquired Specific Diagnostics (US). With this acquisition, bioMerieux will improve its presence in antimicrobial resistance while expanding its market-leading position globally in clinical microbiology.
MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062